@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_head { this: np:hasAssertion dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_assertion; np:hasProvenance dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_provenance; np:hasPublicationInfo dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_publicationInfo; a np:Nanopublication . dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_assertion a np:Assertion . dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_provenance a np:Provenance . dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_publicationInfo a np:PublicationInfo . } dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_assertion { miriam-gene:723961 a ncit:C16612 . lld:C2931689 a ncit:C7057 . dgn-gda:DGNce8b54be0d5cb4696b22165db38edaf4 sio:SIO_000628 miriam-gene:723961, lld:C2931689; a sio:SIO_001121 . } dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_provenance { dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_assertion dcterms:description "[With the aim of investigating glucose-mediated glucose disposal (glucose effectiveness [GE]) in 15 (3 female and 12 male subjects) insulin-resistant normoglycemic relatives of patients with type 2 diabetes (DM2), and 15 age-, sex-, and BMI-matched control subjects without a family history of DM2, we performed 2 studies: 1) a 5-h euglycemic near-normoinsulinemic pancreatic clamp with somatostatin (360 microg/h), insulin (0.25 mU x kg(-1) x min(-1)), glucagon (0.5 ng x kg(-1) x min(-1)), growth hormone (6 ng x kg(-1) x min(-1)), and tritiated glucose infusion and indirect calorimetry; and 2) on a separate day, an identical 5-h clamp but at hyperglycemia (approximately 12 mmol/l) over the last 2 h. Fasting plasma insulin (PI) concentrations were elevated in the relatives compared with control subjects (49 +/- 6 vs. 32 +/- 5 pmol/l, P < 0.04), whereas plasma glucose (PG) was not (5.6 +/- 0.1 vs. 5.5 +/-0.1 mmol/l).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:10909980; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP462422.RADkukRFuA6tpcUgOrc5BggcyGmmlmfx4w_FHUJOIntAs130_publicationInfo { this: dcterms:created "2014-10-02T12:36:35+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }